Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers
Authors:
- Carol O TacketCTCarol O Tacket
- Marcelo B SzteinMSMarcelo B Sztein
- Genevieve A LosonskyGLGenevieve A Losonsky
- Steven S WassermanSWSteven S Wasserman
- Mary K EstesMEMary K Estes
- 1 September 2003
- journal article
- clinical trial
- Published by Elsevier in Clinical Immunology
- Vol. 108 (3) , 241-247
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A Predominant Role for Norwalk‐like Viruses as Agents of Epidemic Gastroenteritis in Maryland Nursing Homes for the ElderlyThe Journal of Infectious Diseases, 2002
- Recombinant Norwalk Virus-Like Particles Administered Intranasally to Mice Induce Systemic and Mucosal (Fecal and Vaginal) Immune ResponsesJournal of Virology, 2001
- The Epidemiology of Enteric Caliciviruses from Humans: A Reassessment Using New DiagnosticsThe Journal of Infectious Diseases, 2000
- Epidemiology of Calicivirus Infections in Sweden, 1994–1998The Journal of Infectious Diseases, 2000
- The Impact of Foodborne Calicivirus Disease: The Minnesota ExperienceThe Journal of Infectious Diseases, 2000
- Structural Studies of Recombinant Norwalk CapsidsThe Journal of Infectious Diseases, 2000
- Production of IFN-γ and IL-10 to Shigella Invasins by Mononuclear Cells from Volunteers Orally Inoculated with a Shiga Toxin-Deleted Shigella dysenteriae Type 1 StrainThe Journal of Immunology, 2000
- Recombinant Norwalk virus–like particles given orally to volunteers: Phase I studyGastroenterology, 1999
- Norwalk Virus Infection among Desert Storm TroopsThe Journal of Infectious Diseases, 1993
- Norwalk Virus Genome Cloning and CharacterizationScience, 1990